# Role of oral hyaluronic acid for joint health: insights from rat models and clinical trials

**Authors:** Botao Wang, Fengli Wang, Tianmeng Zhang, Junying Bai, Shumao Cui, Haining Shi

PMC · DOI: 10.3389/fnut.2025.1691328 · Frontiers in Nutrition · 2025-12-17

## TL;DR

This paper explores how oral hyaluronic acid can help with joint health by reducing arthritis symptoms in rat models and clinical trials.

## Contribution

The study identifies the most effective molecular weight of hyaluronic acid for alleviating osteoarthritis and confirms its clinical benefits.

## Key findings

- High molecular weight hyaluronic acid reduced joint swelling and inflammation in rats.
- Oral hyaluronic acid decreased pain and improved physical function in clinical trials.
- Hyaluronic acid modulated immune responses and reduced cartilage-damaging proteins.

## Abstract

Early studies have demonstrated the significant potential of hyaluronic acid (HA) in alleviating osteoarthritis (OA); however, the relationship between different molecular weights (MWs) and efficacy remains unclear.

The rat model was used to evaluate the effects of different MWs of HA on OA and to identify the MW that was most effective in alleviating OA. Based on this, a clinical trial was conducted to verify the selected HA’s clinical efficacy.

The results showed that HA significantly reduced joint swelling in rats, dramatically increased HA content in the serum and joint synovial fluid, decreased serum and joint synovial fluid levels of pro-inflammatory cytokines, and reduced the expression of matrix metalloproteinases (MMPs), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) when compared with the OA group, especially high-MW HA. Importantly, these protective roles may be attributed to the immune regulation of HA. Clinical trial results indicated that HA significantly decreased pain, stiffness, and physical function of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores and had no significant impact on blood and urine indices.

Our findings suggest that oral supplementation with HA can reduce the progression of arthritis, pain, and cartilage damage, and can be a new strategy to relieve joint discomfort.

## Linked entities

- **Diseases:** osteoarthritis (MONDO:0005178)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 29527] {aka COX-2, Cox2, PGHS-2, PHS II, Pghs2}, Nos2 (nitric oxide synthase 2) [NCBI Gene 24599] {aka Nos2a, iNos}
- **Diseases:** cartilage damage (MESH:D002357), joint swelling (MESH:D007592), inflammatory (MESH:D007249), OA (MESH:D010003), pain (MESH:D010146), arthritis (MESH:D001168)
- **Chemicals:** HA (MESH:D006820)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12754907/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12754907/full.md

## References

47 references — full list in the complete paper: https://tomesphere.com/paper/PMC12754907/full.md

---
Source: https://tomesphere.com/paper/PMC12754907